Skip to main navigation Skip to search Skip to main content

Serum immunoreactive trypsin in cystic fibrosis

  • P. Dandona
  • , M. Hodson
  • , J. Bell
  • , L. Ramdial
  • , I. Beldon
  • , J. C. Batten
  • Royal Free London NHS Foundation Trust

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Abstract

Serum immunoreactive trypsin (IRT) concentrations were measured blind in sera from 33 patients with cystic fibrosis and in 32 age-matched controls. Thirty-two patients had abnormal trypsin concentrations. In 30 of these patients the level of IRT was very low whereas in the other 2 (the youngest of the group) it was extremely high. All 30 patients with low IRT concentrations had clinical or biochemical evidence of malabsorption. Serum IRT concentration may thus be a useful diagnostic test for cystic fibrosis. In view of the recent observation that neonates with cystic fibrosis consistently have raised IRT concentrations, and the fact that the youngest two patients in our series also had markedly increased IRT, it would appear that the initial elevation of IRT reflects early damage to the pancreas with release of enzyme/zymogen; this is thereafter superseded by a progressive destruction of the pancreas reulting in low IRT concentrations in adults with cystic fibrosis.

Original languageEnglish
Pages (from-to)60-62
Number of pages3
JournalUnknown Journal
Volume36
Issue number1
DOIs
StatePublished - 1981

Fingerprint

Dive into the research topics of 'Serum immunoreactive trypsin in cystic fibrosis'. Together they form a unique fingerprint.

Cite this